SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-074289
Filing Date
2022-11-21
Accepted
2022-11-21 17:20:21
Documents
14
Period of Report
2022-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169070-8k_gamida.htm   iXBRL 8-K 42030
2 PRESS RELEASE, DATED NOVEMBER 21, 2022 ea169070ex99-1_gamida.htm EX-99.1 12095
3 GRAPHIC ex99-1_001.jpg GRAPHIC 7344
  Complete submission text file 0001213900-22-074289.txt   242310

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gmda-20221118.xsd EX-101.SCH 3236
5 XBRL LABEL FILE gmda-20221118_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE gmda-20221118_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea169070-8k_gamida_htm.xml XML 3623
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 221406741
SIC: 2836 Biological Products, (No Diagnostic Substances)